DSE:JHRML

JMI Hospital Requisite Manufacturing Limited announcements

103 Dhaka Stock Exchange announcements for JMI Hospital Requisite Manufacturing Limited (JHRML) since 2022: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2026 (17).

  1. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2026 at 3:30 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.

  2. Sale Declaration of a Nominated Director

    Mr. Ranjit Chakraborty, a Nominated Director (nominated by JMI Vaccine Ltd.) of the Company, has expressed his intention to sell his entire holding of 29,634 shares of the Company at the prevailing market price in the public market through Dhaka Stock Exchange PLC. (DSE) within next 30 working days.

  3. Dividend Declaration

    The Board of Directors has recommended 2.50% Cash Dividend only for General Shareholders excluding Sponsors & Directors for the year ended June 30, 2026. The quantity of securities held by the said sponsors and/or directors: 4,04,64,500 shares. The amount payable to the general shareholders is Tk. 2,12,07,405. Date of AGM: 24 January 2027, Time: 11:00 AM, Venue: The AGM venue details will be conveyed through the AGM notice. Record Date: November 26, 2026. (cont.) (Cont. news of JHRML): The Company has also reported consolidated EPS of Tk. 0.71, consolidated NAV per share of Tk. 35.51 and consolidated NOCFPS of Tk. 0.35 for the year ended June 30, 2026 as against consolidated EPS of Tk. 1.86, consolidated NAV per share of Tk. 35.14 and consolidated NOCFPS of Tk. 2.33 for the year ended June 30, 2025. (end)

  4. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (28.10.2026) following its corporate declaration.

  5. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2026 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2026.

  6. Auditor's report regarding status of IPO Proceeds utilization

    JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the Period from 01 April 2026 to 30 June 2026. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/JMI%20Hospital826.pdf

  7. Auditor's report regarding status of IPO Proceeds utilization

    JMI Hospital Requisite Manufacturing Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 January 2026 to March 31, 2026. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/JMI26.pdf

  8. Q3 Financials

    (Q3 Un-audited): Consolidated EPS was Tk. 0.18 for January-March 2026 as against Tk. 0.50 for January-March 2025; Consolidated EPS was Tk. 0.67 for July 2025-March 2026 as against Tk. 1.56 for July 2024-March 2025. Consolidated NOCFPS was Tk. 0.29 for July 2025-March 2026 as against Tk. 0.75 for July 2024-March 2025. Consolidated NAV per share was Tk. 35.47 as on March 31, 2026 and Tk. 35.14 as on June 30, 2025. (cont.) (Cont. News of JHRML): Reasons for Deviation: EPS has decreased because imported raw materials purchases are at high prices compared with sales in the local market (end)

  9. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

  10. Dividend Disbursement

    The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.

  11. Auditor's report regarding status of IPO Proceeds utilization

    JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 October 2025 to 31 December, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JMI%20Hospital%20Requisite_25.pdf

  12. Q2 Financials

    (Q2 Un-audited): Consolidated EPS was Tk. 0.21 for October-December 2025 as against Tk. 0.51 for October-December 2024; Consolidated EPS was Tk. 0.49 for July-December 2025 as against Tk. 1.06 for July-December 2024. Consolidated NOCFPS was Tk. 0.29 for July-December 2025 as against Tk. 0.36 for July-December 2024. Consolidated NAV per share was Tk. 35.63 as on December 31, 2025 and Tk. 35.14 as on June 30, 2025. (cont.) (Cont. News of JHRML): Reasons for deviation: EPS decreased because imported raw material purchases are at high prices compared with sales in the local market. (end)

  13. Regarding revision & time extension for utilization of IPO proceeds

    The company has informed that the shareholders at its 17th AGM held on January 22, 2026, approved the revision of IPO proceeds utilization along with an extension of time up to December 31, 2026. To view details, please visit the following link: https://www.dsebd.org/Annexure/2025/PSI_17th_AGM_IPO_Proceeds_JMI_2026.pdf

  14. Category Change

    The Company will be placed in 'B' category from existing 'A' category with effect from January 25, 2026 as the Company has approved 5% Cash Dividend for the year ended June 30, 2025.

  15. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2026 at 3:30 PM to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended December 31, 2025.

  16. Regarding Date, Time and Venue of the AGM

    Refer to their news disseminated by DSE on 27.10.2025 regarding dividend declaration, the company has further informed that the AGM of the company will be held on 22.01.2026 at 11:00 AM. The AGM will be conducted using digital platform through the link: https://jmihrml.bdvirtualagm.com and physical presence at Sky City Hotel (8th Floor), 47 Siddeshwari, Circular Road, Malibag, Dhaka.

  17. Credit Rating Result

    Alpha Credit Rating PLC. (Alpha Rating) has assigned the Surveillance rating of the Company as "A+" in the long term and "ST-2" in the short term along with Stable outlook based on the audited financial statements up to June 30, 2025 and relevant qualitative information till December 29, 2025.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.